home / stock / tsvt / tsvt quote
Last: | $3.86 |
---|---|
Change Percent: | 0.74% |
Open: | $4.02 |
Close: | $3.86 |
High: | $4.16 |
Low: | $3.84 |
Volume: | 279,983 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.86 | $4.02 | $3.86 | $4.16 | $3.84 | 279,983 | 07-02-2024 |
$4.05 | $3.83 | $4.05 | $4.14 | $3.83 | 574,193 | 07-01-2024 |
$3.85 | $3.8 | $3.85 | $3.85 | $3.7 | 622,287 | 06-28-2024 |
$3.76 | $3.74 | $3.76 | $3.98 | $3.675 | 1,250,636 | 06-27-2024 |
$3.6 | $3.71 | $3.6 | $3.7399 | $3.54 | 761,158 | 06-26-2024 |
$3.76 | $3.86 | $3.76 | $3.9 | $3.72 | 396,789 | 06-25-2024 |
$3.86 | $3.72 | $3.86 | $3.8999 | $3.66 | 502,735 | 06-24-2024 |
$3.72 | $3.81 | $3.72 | $3.865 | $3.7 | 686,211 | 06-21-2024 |
$3.76 | $3.85 | $3.76 | $3.905 | $3.71 | 407,579 | 06-20-2024 |
$3.89 | $4.06 | $3.89 | $4.18 | $3.84 | 306,351 | 06-19-2024 |
$3.89 | $4.06 | $3.89 | $4.18 | $3.84 | 306,351 | 06-18-2024 |
$4.08 | $3.95 | $4.08 | $4.14 | $3.84 | 260,076 | 06-17-2024 |
$3.95 | $4.04 | $3.95 | $4.11 | $3.875 | 195,780 | 06-14-2024 |
$4.09 | $4.2 | $4.09 | $4.2 | $4 | 216,275 | 06-13-2024 |
$4.2 | $4.1 | $4.2 | $4.29 | $3.99 | 530,428 | 06-12-2024 |
$3.93 | $3.88 | $3.93 | $4 | $3.72 | 211,033 | 06-11-2024 |
$3.93 | $3.86 | $3.93 | $3.96 | $3.76 | 563,555 | 06-10-2024 |
$3.915 | $4.03 | $3.915 | $4.03 | $3.87 | 474,382 | 06-07-2024 |
$4.13 | $4.05 | $4.13 | $4.19 | $3.86 | 1,248,951 | 06-06-2024 |
$4.56 | $4.29 | $4.56 | $4.64 | $4.29 | 958,256 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
- Divestiture Supports Company Focus on Development and Commercialization of Abecma - 2seventy bio, Inc . (Nasdaq: TSVT), announced today the completion of an asset purchase agreement (“APA”) by Novo Nordisk. Under the terms of the APA, Novo Nordisk has acquired th...
2024-06-06 06:15:03 ET Goldman Sachs analyst issues SELL recommendation for TSVT on June 6, 2024 05:06AM ET. The previous analyst recommendation was Buy. TSVT was trading at $4.56 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2seventy bio, Inc . (Nasdaq: TSVT) will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can access the conference call live via webcast which will be available on the Investors and Media pa...